PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22438365-2	2012	EAE was induced in SJL mice by using proteolipid protein (PLP), and mice were treated with either 4-aminobenzoic acid hydrazide (ABAH), 40 mg/kg injected intraperitoneally, an irreversible inhibitor of MPO, or saline as control, and followed up to day 40 after induction.	4-aminobenzhydrazide	98-127	myeloperoxidase	Mus musculus	202-205	
22438365-8	2012	Inhibiting MPO activity with ABAH resulted in decrease in MPO-Gd-positive lesion volume (P = .012), number (P = .009), and enhancement intensity (P = .03) at MR imaging, reflecting lower local MPO activity (P = .03), compared with controls.	4-aminobenzhydrazide	29-33	myeloperoxidase	Mus musculus	11-14	
22438365-8	2012	Inhibiting MPO activity with ABAH resulted in decrease in MPO-Gd-positive lesion volume (P = .012), number (P = .009), and enhancement intensity (P = .03) at MR imaging, reflecting lower local MPO activity (P = .03), compared with controls.	4-aminobenzhydrazide	29-33	myeloperoxidase	Mus musculus	58-61	
22438365-8	2012	Inhibiting MPO activity with ABAH resulted in decrease in MPO-Gd-positive lesion volume (P = .012), number (P = .009), and enhancement intensity (P = .03) at MR imaging, reflecting lower local MPO activity (P = .03), compared with controls.	4-aminobenzhydrazide	29-33	myeloperoxidase	Mus musculus	58-61